Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer
Acquired cisplatin resistance in cervical cancer therapy is principally caused by reduction in intracellular drug accumulation, which is exerted by hyperactivation of the oncogenic PI3K/Akt signaling axis and overexpression of cisplatin-exporter MRP2 along with prosurvival effectors NF-κB and IAPs i...
Main Authors: | Elizabeth Mahapatra, Debomita Sengupta, Ravindra Kumar, Budheswar Dehury, Salini Das, Madhumita Roy, Sutapa Mukherjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.803114/full |
Similar Items
-
PEITC: A resounding molecule averts metastasis in breast cancer cells in vitro by regulating PKCδ/Aurora A interplay
by: Souvick Biswas, et al.
Published: (2022-11-01) -
miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
by: Tian-Liang Zheng, et al.
Published: (2019-09-01) -
KRAS is a molecular determinant of platinum responsiveness in glioblastoma
by: Candida Zuchegna, et al.
Published: (2024-01-01) -
Increased Sensitivity to Cisplatin in Non-Small Cell Lung Cancer Cell Lines after FHIT Gene Transfer
by: F. Andriani, et al.
Published: (2006-01-01) -
Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
by: Khan MM, et al.
Published: (2020-03-01)